Personalized pathways
“We are moving to a more precise, proactive, and personalized model of healthcare, and diagnostics are the lens that make that precision possible.”
William Morice II, M.D., Ph.D., president and CEO, Mayo Clinic Laboratories
Advanced diagnostics play a critical role in guiding personalized care for patients with rare diseases. Isabel’s journey demonstrates how specialized laboratory testing delivers diagnostic clarity and supports individualized care decisions. Watch her story to learn more about the impact of Mayo Clinic Laboratories.

Precision care starts with accurate answers
The latest
Autoimmune neurology testing has evolved beyond limited paraneoplastic evaluations to phenotype-specific panels that identify clinically relevant antibodies. This phenotype-specific approach significantly improves diagnostic accuracy, reduces false positives, and helps guide faster, more personalized treatment for complex neurological diseases.
Mayo Clinic Laboratories has developed a cutting-edge suite of Alzheimer's disease testing. The newest assays use blood samples, avoiding the need for lumbar punctures to obtain cerebrospinal fluid. The testing suite exemplifies Mayo Clinic Laboratories' innovative business approach. As a platform company, Mayo Clinic is creating a diagnostics ecosystem to meet a wide range of testing needs and help physicians order the right tests for their patients.